Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Miwako Kobayashi
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR. Morbidity and mortality weekly report
Health Information Management
Mutagenesis
Epidemiology
Health
Medicine
Toxicology
Ultrasound-Guided Rectus Sheath Block for Improvement of Feelings of Abdominal Distension
Palliative Care Research
Related publications
Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
Pediatrics
Child Health
Pediatrics
Perinatology
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis
Epidemiology and Vaccine Prevention
Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children
Pediatric pharmacology
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or No Vaccination (NoVac) in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds With the 13-Valent Pneumococcal Conjugate Vaccine in England
PLoS ONE
Multidisciplinary
Postlicensure Safety Surveillance for 7-Valent Pneumococcal Conjugate Vaccine
JAMA - Journal of the American Medical Association
Medicine
